{
    "2021-06-04": [
        [
            {
                "time": "",
                "original_text": "金域医学：国开博裕减持计划完成，减持股份数约922万股",
                "features": {
                    "keywords": [
                        "金域医学",
                        "国开博裕",
                        "减持",
                        "922万股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "基因测序双周榜：药明康德流通市值暴涨315亿元，核酸检测龙头金域医学“叫好不叫座”？",
                "features": {
                    "keywords": [
                        "基因测序",
                        "药明康德",
                        "金域医学",
                        "核酸检测",
                        "市值暴涨",
                        "叫好不叫座"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "金域医学(603882.SH)股东国开博裕累计减持922.09万股 减持期限届满",
                "features": {
                    "keywords": [
                        "金域医学",
                        "国开博裕",
                        "减持",
                        "922.09万股",
                        "减持期限届满"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "金域医学：股东国开博裕减持计划期限届满，累计减持1.99%股份",
                "features": {
                    "keywords": [
                        "金域医学",
                        "国开博裕",
                        "减持",
                        "1.99%股份"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "基因检测"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}